Pastore LLC successfully negotiated the separation of C-suite executive from a publically traded Boston based bio-tech company. Key issues involved the vesting of stock options and related plan documents, adherence to Rule 144 in the disposition of stock and the scope of non-competition agreements under Delaware law.

Tags: Firm News

More News

2

December2025

Pastore Attorney Tyler W. Rutherford’s Article Published in the Westchester Lawyer

10

September2025

Connecticut Appellate Court Rules in Favor of Pastore LLC’s Hedge Fund Clients in Landmark Jury Trial Decision

12

August2025

Pastore LLC Obtains a $51M PJR Involving the Largest Real Estate Development in Westchester and a Greenwich Based Real Estate Developer
+ View More